Konstantinos Kavallieros

Mr. Konstantinos Kavallieros

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2024 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Open access
KKKonstantinos Kavallieros
Konstantinos Kavallieros
TPTasneem Pope
Tasneem Pope
MTMatthew Tan
Matthew Tan
HKHarmeena Kaur
Harmeena Kaur
SGSergio Gianesini
Sergio Gianesini
ADAlun H. Davies
Alun H. Davies
There is increasing recognition that health systems need to measure and improve the value of patient care by measuring outcomes. Chronic pelvic pain secondary to pelvic venous insufficiency can have a significant impact on the quality of life (QOL) of women affected. Despite growing recognition, pelvic venous disorders (PeVDs), an important cause of chronic pelvic pain, remain underdiagnosed. Developing a core outcome set (COS) for benchmarking care delivery enhances the standardization of care. However, there is no consensus regarding a standardized minimum set of outcomes for PeVD. We aimed to generate a list of outcomes reported in previous PeVD treatment studies to lay the foundation for developing a COS for PeVD. This scoping review was undertaken according to the PRISMA-ScR guidelines. Initially, screening, full-text review and extraction was conducted on studies published between 2018 and 2023. Subsequently, the search was expanded using 1-year intervals, until, over a 1-year interval, no new outcomes were recorded. Closely related outcomes were classified into domains, and domains into three core areas: disease-specific, treatment-related, and QOL-related outcomes. Of the 1579 records identified, 51 publications were included. From these studies, 108 different outcomes were identified. The median number of outcomes per study was 8 (interquartile range, 6-13). Closely related outcomes were organized into 42 outcome domains, which were then categorized into 3 core outcome areas; 47.6% (20/42) were disease specific, 35.7% (15/42) treatment related, and 16.7% (7/42) were QOL related. Of the 51 included studies, disease-specific outcomes were identified in 96.1% of the studies (49/51), treatment-related outcomes in 94.1% (48/51), and QOL outcomes in only 13.7% (7/51). There was significant heterogeneity in outcomes reported in PeVD studies. Most PeVD treatment studies evaluated disease-specific and treatment-related outcomes of PeVD, but few reported outcomes that measured the impact on QOL. These findings will inform the next steps in developing a COS for PeVD.

22 June 2024 in Cancers
Verified
Journal Article
Open access
PDF file
KKKonstantinos Kavallieros
Konstantinos Kavallieros
LKLampros Karakozis
Lampros Karakozis
RHRomilly Kathleen Hayward
Romilly Kathleen Hayward
EGEmmanuel Giannas
Emmanuel Giannas
LSLucio Selvaggi
Lucio Selvaggi
Christos KontovounisiosChristos Kontovounisios
Christos Kontovounisios
Wearable devices are increasingly utilised to monitor patients perioperatively, allowing for continuous data collection and early complication detection. There is considerable variability in the types and usage settings of wearables, particularly within colorectal surgery. To address this, a scoping review was conducted to investigate current utilisation of wearable devices in colorectal surgery. A systematic search across MEDLINE and Embase was conducted following PRISMA Scoping Review guidelines. Results were synthesised narratively, categorised by perioperative phase (preoperative; postoperative; combination), and supplemented with descriptive statistics and tables. Out of 1525 studies initially identified, 20 were included, reporting data on 10 different wearable devices. Use of wearable devices varied across settings with those used preoperatively tending to focus on baseline physical status or prehabilitation, while postoperative use centred around monitoring and identification of complications. Wearable devices can enhance perioperative monitoring, enable proactive interventions, and promote personalised care for improved patient outcomes in colorectal surgery.

4 December 2024 in Health Science Reports
Verified
Journal Article
Open access
MAManal Ahmad
Manal Ahmad
MTMi‐Tra Tran
Mi‐Tra Tran
BABasma Ahmad
Basma Ahmad
KKKonstantinos Kavallieros
Konstantinos Kavallieros
JSJoseph Shalhoub
Joseph Shalhoub
ADAlun Huw Davies
Alun Huw Davies
Introduction: Simulation allows trainees to practice skills safely. It is the current gold standard method of teaching. More recently, novel methods such as virtual reality and augmented reality are being explored as possible alternative methods.Aims: To evaluate the current evidence pertaining to simulation and virtual reality as methods of teaching in teaching trauma management.Methods: Medline and Embase (via Ovid interface) were used to search for articles up to April 2023. A combination of the following MeSH terms were employed in the primary search string ‐ “virtual reality,” “simulation,” “surgery,” “trauma,” and “medical education.”Results: 3815 studies were initially identified. After de‐duplication, 2648 articles were screened using Covidence. Forty articles underwent full text review. Thirteen studies were included in the final review with a pooled total of 489 participants. Significant heterogeneity exists in the range of participants, scenarios and parameters assessed. The overall self‐reported perception of VR as a teaching modality is positive and is well accepted however objective assessment and validation is needed.Conclusion: VR can be useful for training and evaluation of trauma‐based scenarios. It is a useful adjunct but is unlikely to replace simulation at present. More robust and replicable studies with larger sample sizes are needed to evaluate the long‐term integration of virtual reality and augmented reality into the medical and surgical teaching curriculum.

25 April 2024 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Open access
KKKonstantinos Kavallieros
Konstantinos Kavallieros
TPTasneem Pope
Tasneem Pope
KMKonstantinos Mantonanakis
Konstantinos Mantonanakis
MTMatthew Tan
Matthew Tan
SGSergio Gianesini
Sergio Gianesini
ADAlun H. Davies
Alun H. Davies
Pelvic venous disorders (PeVD) encompass a variety of conditions linked to chronic pelvic pain in women. However, PeVD remain underdiagnosed due to the absence of universally accepted diagnostic criteria. The complexity of PeVD classifications across specialties leads to delays in treatment. This scoping review aims to fill a gap in PeVD diagnosis and management by identifying all existing scoring or grading systems to lay the foundation for standardized clinical scoring tools for PeVD. This scoping review was undertaken according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping reviews. Online databases were searched up to April 2023. Studies implementing a scoring or grading system for patients with confirmed or suspected PeVD were included. Scores or grading systems were classified into four main categories based on their use in the study: screening, diagnosis, measure of disease severity, and measure of response to treatment. Of the 2976 unique records identified, 82 were reviewed in full, and 20 were included in this study. The publication dates ranged from 1984 to 2023 (median, 2018; interquartile range, 2003-2022). A total of 21 scores and/or grading systems were identified. Of these 21 scores, 10 (47.6%) were clinical scores, and 10 (47.6%) were scores based on radiological findings; one study included a score that used both clinical and radiological findings. The identified scores were used in various settings. Of the 21 scores, 2 (9.52%) were used for screening in a tertiary care setting; 3 (14.3%) were used to establish the PeVD diagnosis; 8 (38.1%) were used to assess disease severity; and 8 (38.1%) were used as measures of response to treatment. Of the eight scores assessing disease severity, four (50.0%) assessed the degree of dilatation of pelvic veins and four (50%) assessed the severity of reflux. Only three of the scores were validated. This scoping review identified a range of scoring and grading systems for PeVD. We note a lack of a validated scoring system, both clinical and radiological, for screening and assessment of disease severity. This is an important first step in developing validated disease-specific scoring systems for patient screening, appropriate referral, assessment of symptom severity, and assessment of the response to treatment.

23 January 2026 in Phlebology: The Journal of Venous Disease
Verified
Journal Article
Open access
KKKonstantinos Kavallieros
Konstantinos Kavallieros
AGAdam Gwozdz
Adam Gwozdz
BTBenedict Turner
Benedict Turner
GKGiannis Konstantinou
Giannis Konstantinou
EGEmmanuel Giannas
Emmanuel Giannas
ADAlun Huw Davies
Alun Huw Davies
Background: Recurrence of superficial venous incompetence is common following interventional treatment and a classification system (Recurrent Varices After Surgery, REVAS) has been developed. However, it is not known whether specific, predictable patterns of reflux occur following treatment nor how these may vary by treatment modality. This study aimed to explore varicose vein recurrence patterns according to procedural technique. Methods: Following PRISMA guidelines and a registered protocol (CRD42023455512), MEDLINE, Embase, and ClinTrials.gov were searched for randomized control trials (RCTs) on surgical or endovenous treatment of primary saphenous vein insufficiency with at least 1-year follow-up, and assessment of recurrence patterns. The primary outcome was reflux recurrence as per the REVAS classification. A random-effects network meta-analysis was conducted in R, calculating risk ratios and 95% confidence intervals (CIs). Results: The 3467 records identified yielded 23 unique RCTs, investigating 8 different modalities. Recurrence rates varied by anatomical section: saphenofemoral junction (SFJ) showed 23.6% cumulative recurrence, thigh perforators 7.6%, and lower leg perforators 4.7% recurrence. Endovenous laser ablation (EVLA) and foam sclerotherapy (FS) had higher risk of SFJ recurrence compared to HLS with a risk ratio of 2.29 (1.40–3.76) and 2.09 (1.20–3.62) (I 2 = 47.7%). EVLA was associated with a reduced risk of thigh perforator recurrence compared to HLS (0.45, (0.21–0.93)) (I 2 = 0%). FS was associated with higher risk of recanalization compared to HLS (4.05 (2.23–7.35)), and EVLA (3.14 (1.82–5.41)), Both EVLA and FS were associated with lower risk of neovascularization, compared to HLS; 0.28 (0.18–0.43) and 0.18 (0.08–0.40), respectively (I 2 = 0%). Conclusion: Recurrence patterns varied by treatment modality, with HLS showing lower SFJ and ASV recurrence, while endovenous methods had less neovascularization and thigh perforator recurrence. Concerningly, only 13% of RCTs reported recurrence using REVAS. Improved reporting of varicose vein recurrence to delineate reflux sources will allow better technical outcome assessment and enhanced patient care.

21 February 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EGEmmanuel Giannas
Emmanuel Giannas
KKKonstantinos Kavallieros
Konstantinos Kavallieros
TNTheodoros Nanidis
Theodoros Nanidis
JGJohn Giannas
John Giannas
PTParis Tekkis
Paris Tekkis
Christos KontovounisiosChristos Kontovounisios
Christos Kontovounisios
Innovation in surgery and pelvic oncology have redefined the boundaries of pelvic exenteration for CRC. However, surgical approaches and outcomes following repeat exenteration and reconstruction are not well described. The resulting defect from a second beyond Total Mesorectal Excision (TME) presents a challenge to the reconstructive surgeon. The aim of this study was to explore reconstructive options for patients undergoing repeat beyond TME for recurrent CRC following previous beyond TME and regional reconstruction. MEDLINE and Embase were searched for relevant articles, yielding 2353 studies. However, following full text review and the application of the inclusion criteria, all the studies were excluded. This study demonstrated the lack of reporting on re-do reconstruction techniques following repeat exenteration for recurrent CRC. Based on this finding, we conducted a point-by-point discussion of certain key aspects that should be taken into consideration when approaching this patient cohort.